Overall rank by patents
#1,307
of 49,997 tracked assignees
USPTO PatentsView assignee record - 324 granted patents across 55 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data).
The verdict
According to USPTO PatentsView, Express ranks #1,307 of 49,997 tracked US assignees by granted-patent volume, with 324 patents across 55 technology areas.
USPTO PatentsView assignee plate
Corpus R1307 · US Corporation #1,307 · 324 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Ablic Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
California Institute… · near
68 score
Express Scripts… · this assignee
68 score
Imperial College… · near
68 score
Baker Hughes Holdings · near
68 score
Enevate · near
68 score
3D Lighting… · lowest
7 score
What this shows Express's Innovation Score is 68.4/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Between 2020–2024, Express Scripts Strategic Development, Inc. received 251 grants versus 44 in 2015–2019 (+470% equal-window velocity, top decile growth). Across complete PatentsView years, output peaked in 2023 at 68 grants and bottomed in 2017 at 1. Lead class G16H accounts for 48.5% of the portfolio across 55 subclasses. Volume neighbours: Chugai Seiyaku Kabushiki Kaisha (#1,303) and Virginia Tech Intellectual Properties, Inc. (#1,311).
From 2019–2021 to 2022–2024, Express Scripts Strategic Development, Inc. moved from 95 to 180 grants (1.90x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #241. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Chugai Seiyaku Kabushiki Kaisha
325 patents
Continental Reifen Deutschland GmbH
325 patents
Sony Interactive Entertainment America LLC
325 patents
Ablic Inc.
324 patents
PFU Limited
324 patents
The Hong Kong University of Science and Technology
324 patents
UAB 360 IT
324 patents
Virginia Tech Intellectual Properties, Inc.
324 patents
Express Scripts Strategic Development, Inc.
324 patents
What this shows Express holds 324 patents at rank #1,307, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #1,307 in granted patent volume.
Other assignees with the most granted patents in Express's primary technology class.
Two PlainPatent-derived peer sets for Express, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (68 here).
Nearest assignees by average claims per patent (17.9 here).
Express's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
68 Top 1% higher than 99% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 0.3% |
| 2018 | 19 | 5.9% |
| 2019 | 24 | 7.4% |
| 2020 | 39 | 12.0% |
| 2021 | 32 | 9.9% |
| 2022 | 63 | 19.4% |
| 2023 | 68 | 21.0% |
| 2024 | 49 | 15.1% |
| 2025partial year | 29 | 9.0% |
Top 15 of 55 technology areas
Overall rank by patents
#1,307
of 49,997 tracked assignees
68.4 out of 100
What to do with this data
Express Scripts Strategic Development, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.